We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.66B
AUM Growth
Cap. Flow
+$1.66B
Cap. Flow %
100.03%
Top 10 Hldgs %
15.4%
Holding
693
New
693
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 17.27%
2 Technology 10.67%
3 Financials 7.63%
4 Consumer Discretionary 5.41%
5 Industrials 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
26
Microsoft
MSFT
$3.76T
$10.3M 0.62%
+43,899
New +$10.2M
LQD icon
27
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.6B
$9.67M 0.58%
+74,333
New +$9.89M
PFFD icon
28
Global X US Preferred ETF
PFFD
$2.16B
$9.4M 0.56%
+368,570
New +$9.35M
MFT
29
DELISTED
BLACKROCK MUNIYIELD INVESTMENT QUALITY FUND
MFT
$9.18M 0.55%
+632,866
New +$9.18M
ETSY icon
30
Etsy
ETSY
$7.38B
$8.91M 0.54%
+44,159
New +$9.24M
TMO icon
31
Thermo Fisher Scientific
TMO
$222B
$8.87M 0.53%
+19,432
New +$9.27M
NOW icon
32
ServiceNow
NOW
$132B
$8.47M 0.51%
+84,645
New +$8.94M
MDGL icon
33
Madrigal Pharmaceuticals
MDGL
$11.9B
$8.46M 0.51%
+72,342
New +$8.43M
MMD
34
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$281M
$8.34M 0.5%
+376,113
New +$8.19M
VTEB icon
35
Vanguard Tax-Exempt Bond Index Fund
VTEB
$46B
$8.26M 0.5%
+151,123
New +$8.3M
MYOV
36
DELISTED
Myovant Sciences Ltd.
MYOV
$8.22M 0.49%
+399,330
New +$9.09M
BTA
37
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
$8.01M 0.48%
+632,503
New +$8.05M
NZF icon
38
Nuveen Municipal Credit Income Fund
NZF
$2.43B
$7.95M 0.48%
+492,104
New +$7.92M
NVG icon
39
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.68B
$7.59M 0.46%
+449,109
New +$7.5M
NGM
40
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$7.55M 0.45%
+259,841
New +$7.27M
COST icon
41
Costco
COST
$423B
$7.47M 0.45%
+21,197
New +$7.38M
APLS
42
DELISTED
Apellis Pharmaceuticals
APLS
$7.47M 0.45%
+174,056
New +$8.24M
ABT icon
43
Abbott
ABT
$188B
$7.43M 0.45%
+62,003
New +$7.35M
MRK icon
44
Merck
MRK
$323B
$7.42M 0.45%
+100,863
New +$7.44M
INSM icon
45
Insmed
INSM
$29.4B
$7.42M 0.45%
+217,695
New +$8.32M
LEO
46
BNY Mellon Strategic Municipals
LEO
$387M
$7.13M 0.43%
+835,221
New +$7.08M
NEA icon
47
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.41B
$7.13M 0.43%
+480,928
New +$7.12M
OPK icon
48
Opko Health
OPK
$1.04B
$7.08M 0.43%
+1,650,417
New +$7.88M
NMZ icon
49
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.2B
$7.07M 0.42%
+489,840
New +$7.04M
QUAL icon
50
iShares MSCI USA Quality Factor ETF
QUAL
$48.1B
$7M 0.42%
+57,501
New +$6.79M

Similar funds

Hennion & Walsh Asset Management's Q1 2021 Portfolio in Review

Q1 2021 is the first quarter with a 13F filing on record for Hennion & Walsh Asset Management, which disclosed 693 positions worth $1.66B. Its ten largest holdings account for 15% of the portfolio.

Its largest position is Goldman Sachs ActiveBeta US Large Cap Equity ETF: 546,261 shares worth $43.2M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, followed by Technology and Financials.

  • Hennion & Walsh Asset Management's largest Q1 2021 buy was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 546,261 shares worth $43.2M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 15% of its $1.66B portfolio in Q1 2021.
  • Hennion & Walsh Asset Management disclosed 693 positions in Q1 2021, its first 13F filing on record.

Based on Hennion & Walsh Asset Management's 13F filing for Q1 2021, filed 17 May 2021.